Aiyar gave 'supari' in Pakistan to get me 'removed': PM Modi

Agencies
December 9, 2017

Bhabhar (Guj), Dec 9: Prime Minister Narendra Modi accused suspended Congress leader Mani Shankar Aiyar of giving 'supari' (contract) while on a visit to Pakistan to get him "removed" from the way to ensure peace between India and the neighbouring country.

Targeting the diplomat-turned politician for the second time in two days after the Congress leader's 'neech aadmi'(lowly person) jibe at him yesterday, Modi also alleged that the Congress tried to suppress this episode and did not take any action against Aiyar.

Attacking the Congress over its work culture, Modi alleged that the party believes in--'atkana' (to stall) 'latkana' (to keep the issue hanging) and 'bhatkana' (to divert an issue).

The prime minister's remarks come a day after Aiyar set off a political firestorm when he called Modi a "neech kism ka aadmi". The Congress yesterday suspended Aiyar from the primary membership of the party and issued him a show cause notice for his remarks.

"Shriman Mani Shankar Aiyar...you know what he did?" Modi asked a gathering of people in this small town of Banaskantha district in North Gujarat.

"He gave this 'gaali' (abuse) to me or you? Did he abuse me or Gujarat? Did he abuse the cultured society of India or me?" Modi asked.

"Let us not talk about that abuse, as people of Gujarat will look into it and give a reply and they (Congress) will know the result on December 18," he said.

"But, after I became prime minister, this man (Aiyar) went to Pakistan and met some Pakistanis. All this thing is available on the social media. In that meeting, he is seen discussing with Pakistanis that 'jab tak Modi ko raste se hataya nahi jata' (until Modi is not removed from the way), relationship between India and Pakistan cannot improve," Modi added.

"Someone tell me what is the meeting of 'raste se hatana'. You had gone to Pakistan to give my 'supari', you wanted to give Modi's 'supari' (contract killing)," the PM said.

However, people need not worry as 'Maa Ambe' (goddess) is protecting me, he added.

"This conversation took place three years back. The Congress party had tried to suppress this episode...They did not take any action against him for last three years," Modi alleged.

"What is my crime? This country's people have elected me in a democratic way, and you go to Pakistan and say that this man is coming in the way and remove him!" he said. Modi was referring to a controversy that had erupted in 2015 when Aiyar during a talk show in Pakistan had reportedly made the controversial statement. Yesterday, during a rally in Surat, he had said, "Shriman (Mr) Mani Shankar Aiyar today said that Modi is of 'neech' (lower) caste and is 'neech' (lowly). Is this not an insult to Gujarat?...This is a Mughal mentality where if such a person (who comes from a humble background) wears good clothes in a village, they have a problem."

During today's rally, Modi further said the issue here is of Congress' mentality and the party's work culture means "atkana, latkana and bhatkana".

"What Congress has done so far is-atkana, latkana and bhatkana. They will either stall, keep an issue hanging or try to divert it," Modi said adding that they are not interested in solving people's problems.

When our brave jawans conducted the surgical strike then, I think that all the people of the country felt proud, but only Congress was not happy, he said.

"They raised questions about the surgical strike- did this (surgical strike) happen or not? Pakistan is saying that it did not happen...why none of our soldiers were killed... Would you believe Pakistan or India in such matters?" Modi asked.

Comments

Jameel
 - 
Monday, 11 Dec 2017

modi, are you worth the supari. hehehe.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 11,2020

New Delhi, Jan 11: Assets worth Rs 78 crore have been attached by the ED in connection with a money laundering probe against former ICICI Bank Chairman Chanda Kochhar and others, officials said on Friday.

A provisional order under the Prevention of Money Laundering Act (PMLA) has been issued for attachment of the properties that includes Kochhar's Mumbai-based house and some other assets belonging to a company linked to her, they said.

The book value of the attached assets is Rs 78 crore, they said.

The Enforcement Directorate (ED) is probing Kochhar, her husband Deepak Kochhar and others in a case of alleged irregularities and money laundering in giving loans by the bank to the Videocon group.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 13,2020

New Delhi, Jul 13: The Land & Development Office, which comes under the Union Ministry of Housing and Urban Affairs, has sent a notice to news agency PTI, demanding it to cough up more than Rs 84 crore as penalty. The notice dated July 7 says that the penalty has been imposed due to "breaches" at its office in Delhi.

The notice that sought Rs 84,48,23,281 argues that "the less will be pleased to regularise the breaches in the premises temporarily up to 14.07.2020 and withdraw the right of re-entry of the premises subject to the following conditions being fulfilled by you within 30 days from the date of issue of this letter."

The notice also stipulates that the news agency needs to give an undertaking on non-judicial stamp paper stating that it will pay the difference of "misuse/damage charges" if the land rates are revised with effect from 01.04.2016 by the government and will also remove the "breaches" by 14.07.2020 or get them regularised by paying charges.

The notice also warns that further action to execute the deed has to be subject to complete payment and putting the premise to use according to the masterplan.

The Land & Development Office so warned that an additional 10 per cent interest may need to be coughed out by PTI if it fails to furnish the concerned amount within the stipulated time period.

Additionally, if the news agency fails to comply with the terms within the said period, the concession will be withdrawn. In other words, they will have to pay the penalty up to the actual date of payment then and will also be subject to actions.

This stern notice for alleged violations by PTI comes closely on the heels of national broadcaster Prasar Bharati locking horns with PTI over its reportage that it called "anti national".

Prasar Bharti had recently sent a letter threatening to end its "relationship" with PTI after it carried an interview of Chinese Ambassador Sun Weidong, where he blamed India for the India-China violent standoff that saw 20 Indian bravehearts getting martyred.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.